Navigation Links
US Prescription Medical Food Company Appoints Board of International Advisors

SCOTTSDALE, Ariz., April 10, 2013 /PRNewswire/ -- Prismic Pharmaceuticals, Inc., a Scottsdale, Arizona-based, emerging pharmaceutical company specializing in prescription Medical Foods, today announced the appointment of a number of International Advisors to its International Commercial Advisory Board.  Board members will act as a "sounding board" for Prismic's senior management and Board of Directors in terms of providing input and opinions regarding pharmaceutical/healthcare industry developments, latest trends and practices on a local and international basis.  Recently appointed advisors include: 

  • Antoni Esteve , Ph.D., (Spain) who is a member of the Board of Directors of Laboratorios del Dr. Esteve, S.A., one of Spain's largest pharmaceutical and chemical manufacturing companies with operations in 40 countries and a presence in more than 60.  
  • Cosimo Pulli, Ph.D., (Italy) who serves as the senior executive responsible for Emerging Markets at Chiesi Farmaceutici Spa, one Italy's major pharmaceutical companies and the leader in R&D investment.  
  • Massimo Bonsi , (Eastern Europe) who is the Founder and CEO of the Solartium Group based in Bucharest, Romania, and who has significant pharmaceutical industry knowledge and expertise in the Eastern European region.
  • Anthony H. Wild , Ph.D., (International) the former President of Warner-Lambert's Parke-Davis global Pharmaceutical business.  Currently, Dr. Wild is a member of the Board of Directors of Ranbaxy Laboratories and several privately-owned specialty pharmaceutical companies. He also is on the board of advisors of Auven Therapeutics, a pharmaceutical venture fund. 

Additionally, Prismic has appointed Marco Cartolari, the founder and, until its recent acquisition, CEO of Scharper SpA, as a Special Advisor to the Board of Directors. Under Cartolari's leadership, Scharper pioneered the development of nutraceuticals and highly scientific "medical food" type products in Italy, and promoted/detailed those products to physicians via Scharper's own sales force

Commenting on these appointments, Peter Moriarty , the Chairman and CEO of Prismic Pharmaceuticals stated, "Prismic is honored to have such a distinguished group of International Advisors.  Their pharmaceutical industry knowledge and perspectives will be of great value to our senior management team and our Board of Directors."

About Prismic Pharmaceuticals, Inc.
Prismic Pharmaceuticals, Inc., is a privately held pharmaceutical company focused on the development and marketing of prescription medical foods for the clinical dietary management of the metabolic processes associated with many of the disorders associated with the aging population, particularly where inflammation is involved.  The company is based in Scottsdale, Arizona, and was founded in 2011. Contact 480.422.1810 or visit

Peter Moriarty
Tel: 480.422.1810

SOURCE Prismic Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Cardinal Health Foundation, The Ohio State University Launch Fourth Toolkit to Help Reduce Abuse of Prescription Drugs on College Campuses
2. Recreational Marijuana Users More Likely To Misuse Prescription Drugs, According to National Study by Quest Diagnostics
3. Prescription Drug Misuse Remains at Alarming Levels, According to National Study by Quest Diagnostics
4. CADCA Chairman And CEO To Discuss Costs Of Prescription Drug Abuse At National Rx Drug Abuse Summit
5. Watertree Health Rolls Out National Prescription Discount Card Program
6. Independent Drugstore Lobby Wants Sweeping Antitrust Exemptions to Charge Higher Prescription Drug Prices
7. The Essential Guide to Prescription Drugs, 12 Top Meds for 2012 available!
8. New Study Debunks Wastage Myths of Prescriptions Filled in Medicare Part D
9. US Spending on Traditional Prescription Drugs Fell in 2012 for First Time on Record
10. New Direct-to-Consumer Prescription Delivery Channel Mitigates Risk of Medication Non-Adherence Highlighted in JAMA Internal Medicine Study
11. Study Shows Medicare Savings When Local Pharmacies Fill 90-Day Prescriptions
Post Your Comments:
(Date:6/23/2016)... -- Research and Markets has announced the addition ... - Forecast to 2022" report to their offering. ... to date financial data derived from varied research sources to ... potential impact on the market during the next five years, ... of sub markets, regional and country level analysis. The report ...
(Date:6/23/2016)... June 23, 2016 , , ... July 7, 2016 , , , , LOCATION: , , ... , , , EXPERT PANELISTS:  , , , Frost & ... Analyst, Christi Bird; Senior Industry Analyst, Divyaa Ravishankar and Unmesh Lal, ... The global pharmaceutical industry is witnessing an exceptional era. Several new ...
(Date:6/23/2016)... -- Guerbet announced today that it has been named a ... One of 12 suppliers to receive the ... of Premier members through exceptional local customer service and ... lower costs. "We ... customer service from Premier," says Massimo Carrara , ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... June 25, 2016 , ... Experts from the American Institutes ... Research Meeting June 26-28, 2016, at the Hynes Convention Center in Boston. , ... advance care planning, healthcare costs and patient and family engagement. , AIR researchers ...
(Date:6/25/2016)... Miami, FL (PRWEB) , ... June 25, 2016 , ... The temporary closing of Bruton ... Plant City Observer , brings up a new, often overlooked aspect of head lice: ... The closing for fumigation is not a common occurrence, but a necessary one in the ...
(Date:6/25/2016)... ... 25, 2016 , ... First Choice Emergency Room , the largest network ... the Medical Director of its new Mesquite-Samuell Farm facility. , “We are pleased ... location,” said Dr. James M. Muzzarelli, Executive Medical Director of First Choice Emergency Room. ...
(Date:6/25/2016)... ... June 25, 2016 , ... ... recover from injury. Recently, he has implemented orthobiologic procedures as a method for ... is one of the first doctors to perform the treatment. Orthobiologics are substances ...
(Date:6/25/2016)... ... 2016 , ... Conventional wisdom preaches the benefits of moderation, whether it’s a ... the bar too high can result in disappointment, perhaps even self-loathing. However, those who ... , Research from reveals that behind the tendency to set ...
Breaking Medicine News(10 mins):